OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
23 hedge funds and large institutions have $11.1M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.49M | |
| 2 | +$722K | |
| 3 | +$350K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$254K |
| 5 |
EP
Eversept Partners
New York
|
+$201K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$841K | |
| 3 | -$781K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$245K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$79.8K |